Investigación
Educación
Iniciar sesión
ES
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
Department of Biomedical Engineering,
Knight Cancer Institute,
Department of Biomedical Engineering, Knight Cancer Institute
Laura Heiser has not added Biography.
If you are Laura Heiser and would like to personalize this page please email our Author Liaison for assistance.
Pathway-Enriched Gene Signature Associated with 53BP1 Response to PARP Inhibition in Triple-Negative Breast Cancer.
Molecular cancer therapeutics Dec, 2017 | Pubmed ID: 28958991
Maintenance of MYC expression promotes de novo resistance to BET bromodomain inhibition in castration-resistant prostate cancer.
Scientific reports Mar, 2019 | Pubmed ID: 30846826
BET bromodomain inhibition blocks the function of a critical AR-independent master regulator network in lethal prostate cancer.
Oncogene Apr, 2019 | Pubmed ID: 30996246
Oregon Health and Science University
Rebecca Smith1,
Kaylyn Devlin1,
David Kilburn1,
Sean Gross1,
Damir Sudar2,
Elmar Bucher1,
Michel Nederlof2,
Mark Dane1,
Joe W. Gray1,
Laura Heiser1,
James E. Korkola1
1Department of Biomedical Engineering, Knight Cancer Institute, Oregon Health and Science University,
2, Quantitative Imaging Systems LLC
Privacidad
Condiciones de uso
Políticas
Contáctenos
RECOMIENDE A LA BIBLIOTECA
BOLETINES de JoVE
JoVE Journal
Colecciones de métodos
JoVE Encyclopedia of Experiments
Archivo
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centro de recursos académicos
Autores
Bibliotecarios
Acceso
ACERCA DE JoVE
Copyright © 2024 MyJoVE Corporation. Todos los derechos reservados